News
-
MKS is expanding its Guangzhou plant for semiconductor manufacturing equipment. The $25m project will add fabrication systems, technical capacity and industrial jobs, with completion now targeted for 2027.
-
Sourceability plans expanded testing and warehousing capacity across two countries. Its Hungary laboratory and Singapore distribution centre are growing alongside new component supply agreements and procurement monitoring tools.
-
Reju is developing regenerated polyester fabrics with six international mills. The collaborations span knitting, technical weaving, dyeing and finishing, alongside planned investment in industrial recycling capacity.
-
Evonik reports higher chemical volumes alongside sharply stronger quarterly earnings. Its production businesses benefited from improved pricing and demand, while restructuring provisions and proposed portfolio disposals remain substantial.
-
German chemical industry sentiment weakened despite stronger domestic factory orders. The ifo survey recorded a sharp fall in expectations during October, while capacity utilisation increased and companies continued preparing for restructuring.
-
Siemens and Lufthansa Technik plan rail-based evacuation for injured patients. Their proposed German system could transport more than 150 people requiring medical care, using adaptable passenger coaches and established aeromedical equipment.
-
Siemens has introduced coordinated drives for battery-powered industrial mobile robots. Its Sinamics E210 converters and Simotics E-1EE1 servomotors target 24V and 48V vehicles, combining traction control, automation connectivity and safety functions.
-
AGC Biologics has expanded a major cross-border biologics manufacturing agreement. Six additional commercial programmes will run through Copenhagen alongside five at Yokohama, combining process transfer, validation and manufacturing in a dual-site supply arrangement.
-
RWE has secured contracts for three proposed German gas-fired stations. The hydrogen-compatible projects total about 2.1GW of tender-recognised capacity and are designed to supply electricity when wind and solar output is insufficient.
-
Lonza has agreed to buy five US pharmaceutical manufacturing sites. The proposed acquisition from Merck KGaA adds specialised bioconjugation, viral vector and drug-delivery capabilities, alongside approximately 1,100 employees, subject to closing conditions.
© 2b Publishing 2026.